Inhibition of preadipocyte differentiation and lipid accumulation by 7-O-galloyl-d-sedoheptulose treatment in 3T3-L1 adipocytes

Biomedicine and Preventive Nutrition

Volumn 3, Issue 4, 2013, Pages 319-324

  Park, Chan Hum ^a   Rhyu, Dong Young ^b   Sharma, Bhesh Raj ^b   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Mokpo National University   (South Korea)

Author keywords

3T3 L1 cell; 7 O Galloyl d sedoheptulose; Adipogenesis; AMPK; C EBP ; PPAR ; SREBP1c

Indexed keywords

7 O GALLOYL DEXTRO SEDOHEPTULOSE; CCAAT ENHANCER BINDING PROTEIN ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IRIDOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; INHIBITION KINETICS; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84889595634     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2013.03.012     Document Type: Article

References (28)

1. Ahn J., Lee H., Kim S., Park J., Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 2008, 373:545-549.
2. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
3. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005, 338:694-699.
4. Shepherd P.R., Gnudi L., Tozzo E., Yang H., Leach F., Kahn B.B. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice over expressing GLUT4 selectively in adipose tissue. J Biol Chem 1993, 268:22243-22246.
5. Sorisky A. From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus. Crit Rev Clin Lab Sci 1999, 36:1-34.
6. Hwang H.S., Kim S.H., Yoo Y.G., Chu Y.S., Shon Y.H., Nam K.S., et al. Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes. Mar Biotechnol 2009, 11:161-168.
7. Hataguchi Y., Tai H., Nakajima H., Kimata H. Drinking deep-sea water restores mineral imbalance in atopic eczema/dermatitis syndrome. Eur J Clin Nutr 2005, 59:1093-1096.
8. Bubela T., Boon H., Caulfield T. Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals. BMC Med 2008, 6:35.
9. Yamabe N., Kang K.S., Goto E., Tanaka T., Yokozawa T. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol Pharm Bull 2007, 30:520-526.
10. Yamabe N., Kang K.S., Matsuo Y., Tanaka T., Yokozawa T. Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats. Biol Pharm Bull 2007, 30:1289-1296.
11. Yokozawa T., Park C.H., Noh J.S., Tanaka T., Cho E.J. Novel action of 7-O-galloyl-d-sedoheptulose isolated from Corni Fructus, as a hypertriglyceridaemic agent. J Pharm Pharmacol 2009, 61:653-661.
12. Yamabe N., Kang K.S., Park C.H., Tanaka T., Yokozawa T. 7-O-Galloyl-d-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol Pharm Bull 2009, 32:657-664.
13. Park C.H., Noh J.S., Yamabe N., Kang K.S., Tanaka T., Yokozawa T. Beneficial effect of 7-O-galloyl-d-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice. Eur J Pharmacol 2010, 640:233-242.
14. Farrigan C., Pang K. Obesity market overview. Nat Rev Drug Discov 2002, 1:257-258.
15. Fisslthaler B., Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 2009, 105:114-127.
16. Daval M., Foufelle F., Ferré P. Functions of AMP-activated protein kinase in adipose tissue. J Physiol 2006, 574:55-62.
17. Viollet B., Foretz M., Guigas B., Horman S., Dentin R., Bertrand L., et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 2006, 574:41-53.
18. Wu Z., Xie Y., Bucher N.L.R., Farmer S.R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev 1995, 9:2350-2363.
19. Shimano H. SREBPs: physiology and pathophysiology of the SREBP family. FEBS J 2009, 276:616-621.
20. Park C.H., Noh J.S., Tanaka T., Yokozawa T. 7-O-Galloyl-d-sedoheptulose ameliorates renal damage triggered by reactive oxygen species-sensitive pathway of inflammation and apoptosis. J Pharm Pharmacol 2012, 64:1730-1740.
21. Fryer L.G., Carling D. AMP-activated protein kinase and the metabolic syndrome. Biochem Soc Trans 2005, 33:362-366.
22. Kong C.S., Kim J.A., Kim S.K. Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes. Food Chem Toxicol 2009, 47:2401-2406.
23. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
24. Hagen R.M., Rodriguez-Cuenca S., Vidal-Puig A. An allostatic control of membrane lipid composition by SREBP1. FEBS Lett 2010, 584:2689-2698.
25. Kohjima M., Higuchi N., Kato M., Kotoh K., Yoshimoto T., Fujino T., et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 2008, 21:507-511.
26. Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., et al. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008, 48:1477-1486.
27. Zhang X., Ji J., Yan G., Wu J., Sun X., Shen J., et al. Sildenafil promotes adipogenesis through a PKG pathway. Biochem Biophys Res Commun 2010, 396:1054-1059.
28. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 2006, 4:263-273.